跳至主要内容
临床试验/NCT05423756
NCT05423756已完成不适用

The INSPIRE-ASP Trial (INtelligent Stewardship Prompts to Improve Real-Time Empiric Antibiotic Selection for Patients) for Skin and Soft Tissue (SST) Infections

Harvard Pilgrim Health Care204 个研究点 分布在 1 个国家目标入组 118,562 人开始时间: 2023年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
118,562
试验地点
204
主要终点
Extended-Spectrum Days of Antibacterial Therapy (ES-DOT) Per Empiric Day

研究概览

简要总结

The INSPIRE Skin and Soft Tissue Infection trial is a cluster-randomized controlled trial of HCA Healthcare hospitals comparing routine empiric antibiotic stewardship practices with real-time, precision medicine computerized physician order entry (CPOE) smart prompts providing the probability that a non-critically ill adult admitted with skin and soft tissue infection is infected with a resistant pathogen.

Note: enrolled "subjects" represent 102 individual HCA Healthcare hospitals that have been randomized into 92 clusters. Hospitals were grouped into the same randomization cluster if they shared campuses or antibiotic stewardship staff.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Facility Inclusion Criteria:
  • HCA Healthcare hospitals admitting adults for skin and soft tissue infection
  • Facility use of MEDITECH as their electronic health record system

排除标准

  • Note: unit of randomization is the hospital, however the computerized physician order entry (CPOE) alert intervention will calculate risk estimates for adults age >=18 admitted to non-intensive care unit wards and who are ordered to receive extended-spectrum antibiotics for skin and soft tissue infection.

研究组 & 干预措施

Arm 2: INSPIRE Stewardship Bundle

Active Comparator

Use of computerized physician order entry (CPOE) smart prompts, clinician feedback, and activities to support CPOE adoption (including education and alignment of CPOE workflows) to guide empiric choice of antibiotics for skin/soft tissue infection in the first 3 days of hospitalization.

干预措施: Arm 2: INSPIRE Stewardship Bundle for Skin and Soft Tissue Infection (Other)

Arm 1: Routine Care

Active Comparator

Continuation of routine antibiotic stewardship strategies.

干预措施: Arm 1: Routine Care (Other)

结局指标

主要结局

Extended-Spectrum Days of Antibacterial Therapy (ES-DOT) Per Empiric Day

时间窗: First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods

Days-of-Therapy is a standardized national measure for antibacterial use in hospitals that counts each different antibiotic administered on each calendar day as one day of therapy, regardless of doses given. Extended-spectrum days-of-therapy per empiric day is defined as the summed number of different extended-spectrum antibiotics received per patient each calendar day, beginning at admission. If an admission is less than 3 days, only the number of days the patient is admitted will contribute to the numerator and denominator. For example, 2 different extended-spectrum antibiotics administered at least once during each of the first 3 days would yield 6 days of extended-spectrum days-of-therapy.

Extended-Spectrum Days of Antibacterial Therapy (ES-DOT) Per Empiric Day

时间窗: First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods

Days-of-Therapy is a standardized national measure for antibacterial use in hospitals that counts each different antibiotic administered on each calendar day as one day of therapy, regardless of doses given. Extended-spectrum days-of-therapy per empiric day is defined as the summed number of different extended-spectrum antibiotics received per patient each calendar day, beginning at admission. If an admission is less than 3 days, only the number of days the patient is admitted will contribute to the numerator and denominator. For example, 2 different extended-spectrum antibiotics administered at least once during each of the first 3 days would yield 6 days of extended-spectrum days-of-therapy.

次要结局

  • Antipseudomonal Antibiotic Days Of Therapy (ES-DOT) Per Empiric Day(First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods)
  • Antipseudomonal Antibiotic Days Of Therapy (ES-DOT) Per Empiric Day(First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Richard Platt

MD, MSc, Professor and Chair, Department of Population Medicine

Harvard Pilgrim Health Care

研究点 (204)

Loading locations...

相似试验